Literature DB >> 24501340

Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.

Nacho Aguilo1, Ana Maria Toledo, Eva Maria Lopez-Roman, Esther Perez-Herran, Eamonn Gormley, Joaquin Rullas-Trincado, Iñigo Angulo-Barturen, Carlos Martin.   

Abstract

Worldwide, the Mycobacterium bovis BCG vaccine is one of the most widely used vaccines. However, it appears to be ineffective in preventing pulmonary tuberculosis. Here, we show that pulmonary BCG vaccination of mice with a broad dose range provides superior protection against Mycobacterium tuberculosis challenge compared to that of subcutaneous vaccination.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24501340      PMCID： PMC3993116          DOI： 10.1128/CVI.00700-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  18 in total

1.  CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

Authors:  I V Lyadova; S Oberdorf; M A Kapina; A S Apt; S L Swain; P C Sayles
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

2.  Aerosol BCG treatment of carcinoma metastatic to the lung: a phase I study.

Authors:  F B Garner; C A Meyer; D S White; A Lipton
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

3.  Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis.

Authors:  V Gruppo; I M Orme
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

4.  Aerogenic BCG vaccination against tuberculosis in animal and human subjects.

Authors:  S R Rosenthal; J T McEnery; N Raisys
Journal:  J Asthma Res       Date:  1968-06

5.  Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization.

Authors:  Umaimainthan Palendira; Andrew G D Bean; Carl G Feng; Warwick J Britton
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice.

Authors:  J Wakeham; J Wang; Z Xing
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Authors:  Nilu P Goonetilleke; Helen McShane; Carolyn M Hannan; Richard J Anderson; Roger H Brookes; Adrian V S Hill
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

Authors:  E L Nuermberger; T Yoshimatsu; S Tyagi; W R Bishai; J H Grosset
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.

Authors:  J A Tree; A Williams; S Clark; G Hall; P D Marsh; J Ivanyi
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330
View more
  17 in total

1.  Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.

Authors:  Steven C Derrick; Kristopher Kolibab; Amy Yang; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2014-08-20

2.  Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice.

Authors:  Santiago Uranga; Dessislava Marinova; Carlos Martin; Nacho Aguilo
Journal:  J Vis Exp       Date:  2016-09-19       Impact factor: 1.355

3.  Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.

Authors:  Sherry L Kurtz; Karen L Elkins
Journal:  Clin Vaccine Immunol       Date:  2015-08-12

4.  Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung.

Authors:  Paul Ogongo; Liku B Tezera; Amanda Ardain; Shepherd Nhamoyebonde; Duran Ramsuran; Alveera Singh; Abigail Ng'oepe; Farina Karim; Taryn Naidoo; Khadija Khan; Kaylesh J Dullabh; Michael Fehlings; Boon Heng Lee; Alessandra Nardin; Cecilia S Lindestam Arlehamn; Alessandro Sette; Samuel M Behar; Adrie Jc Steyn; Rajhmun Madansein; Henrik N Kløverpris; Paul T Elkington; Alasdair Leslie
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

5.  Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.

Authors:  S Sharpe; A White; C Sarfas; L Sibley; F Gleeson; A McIntyre; R Basaraba; S Clark; G Hall; E Rayner; A Williams; P D Marsh; M Dennis
Journal:  Tuberculosis (Edinb)       Date:  2016-10-08       Impact factor: 3.131

6.  Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.

Authors:  Carolina Perdomo; Ulrike Zedler; Anja A Kühl; Laura Lozza; Philippe Saikali; Leif E Sander; Alexis Vogelzang; Stefan H E Kaufmann; Andreas Kupz
Journal:  mBio       Date:  2016-11-22       Impact factor: 7.867

Review 7.  TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Authors:  Stefan H E Kaufmann; Hazel M Dockrell; Nick Drager; Mei Mei Ho; Helen McShane; Olivier Neyrolles; Tom H M Ottenhoff; Brij Patel; Danielle Roordink; François Spertini; Steffen Stenger; Jelle Thole; Frank A W Verreck; Ann Williams
Journal:  Front Immunol       Date:  2017-10-04       Impact factor: 7.561

Review 8.  The Humoral Immune Response to BCG Vaccination.

Authors:  Rachel Tanner; Bernardo Villarreal-Ramos; H Martin Vordermeier; Helen McShane
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

9.  Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.

Authors:  Seung Bin Cha; Woo Sik Kim; Jong-Seok Kim; Hongmin Kim; Kee Woong Kwon; Seung Jung Han; Seok-Yong Eum; Sang-Nae Cho; Sung Jae Shin
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.

Authors:  Yu-Min Chuang; Michael L Pinn; Petros C Karakousis; Chien-Fu Hung
Journal:  Front Cell Infect Microbiol       Date:  2018-02-08       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.